Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19
Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18
Hyperglycemia-related risk factors in enteral nutrition in non-critically ill patients
Esther Delgado-García; Juan José López-Gómez; Rebeca Jiménez-Sahagún; Emilia Gómez-Hoyos; Ana Ortolá-Buigues; Paloma Pérez-López; Beatriz Torres-Torres; Daniel A. De Luis-Román;
Endocrinol Diabetes Nutr. 2025;72:
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89